Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial

BACKGROUND: It is widely acknowledged that HPV prophylactic vaccine could prevent new infections and their associated lesions among women who are predominantly HPV-naive at vaccination. Yet there still remains uncertainty about whether HPV vaccination could benefit to individuals who have undergone...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuang, Hu, Shangying, Xu, Xiaoqian, Zhang, Xun, Pan, Qinjing, Chen, Feng, Zhao, Fanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667753/
https://www.ncbi.nlm.nih.gov/pubmed/33198657
http://dx.doi.org/10.1186/s12879-020-05560-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667753/
https://www.ncbi.nlm.nih.gov/pubmed/33198657
http://dx.doi.org/10.1186/s12879-020-05560-z

Ejemplares similares